Nicholas Fischer
Managing Associate
Europe
London
Nick is an Associate at Marks & Clerk Law and patent litigator with experience advising across a variety of fields encompassing life sciences, chemistry, telecommunications, engineering and medicinal devices. Nick also has experience advising on regulatory issues in the life sciences sector, including supplementary protection certificates.
Nick’s degree in Cell Biology, including a year spent in the lab during his Master’s degree, means he is well equipped to assist with complex technical disputes with a high level of scientific or technical content.
Nick trained and qualified as a solicitor at a leading London IP firm before joining Marks & Clerk Law in January 2020.
Alongside his work commitments, Nick sits on the committee of IP Ability, and is a Stambassador for the charity Action for Stammering Children.
Outside of work, Nick is an avid rugby fan, still lacing up his boots when he can, and sings in a choir in London.
Connect with Nicholas via LinkedIn or get in touch!
Experience
- Life Sciences Sector: experienced in pharmaceuticals and biotechnology including therapeutic antibodies, vaccines, small molecule drugs, and medical devices.
- Mechanical: experienced in a variety of mechanical patents including telehandlers.
- Other experience: advice relating to supplementary protection certificates and other regulatory issues including data/market exclusivity and orphan drug designations.
Key cases
- Merck Sharp & Dohme v Wyeth
- Merck Sharp & Dohme v Pfizer
- Regeneron and Teva v Pfizer
- JCB v Manitou
Nicholas Fischer works in the following sectors
Biotechnology
Chemical
Medical devices
Pharmaceutical
Telecommunications
Specialist in
Qualifications
Postgraduate Diploma in Intellectual Property Law and Practice, University of Oxford (2017)
Qualified as a Solicitor in England & Wales (2016)
Legal Practice Course, BPP London (2013)
Graduate Diploma in Law, BPP London (2012)
MSc Plant Cell Biology, University of Durham (2011)
BSc (Hons) Cell Biology, University of Durham (2010)
Search our people
Latest Insights
From 01 November 2023, the EPO will abolish the "10-Day Rule"
As has been widely reported, the so-called “10-day rule” at the European Patent Office is being abolished from 1 November 2023. This means that the manner in which many official deadlines are calculated will be changing.
Read more
Polymers, parameters and product-by-process claims
Last year, our colleague Peter Youle wrote about the pitfalls of parameters in patent claims. Whilst small molecules are typically claimed using structural features and formulae, these are usually unsuitable for defining a polymer. Instead, parameters, such as the weight average molecular weight (Mw), are frequently used to characterise polymers.
Read more
Marks & Clerk's third annual AI report continues to generate headlines in tech media
Earlier this month, Marks & Clerk released its third annual AI Report which provides insights into the global AI landscape and highlights key patent trends. This report has continued to gain coverage in Digitalisation World, Financial IT, and Datacentre Solutions – three prominent publications in the technology and business world.
Read more